SPEAKERS Abbas Walji Senior Director, Discovery Chemistry Merck Cameron Pye Chief Executive Officer Unnatural Products Christian Cunningham Chief Scientific Officer PeptiDream Inc. David J. Brayden Professor of Advanced Drug Delivery University College Dublin Dehua Pei Professor of Chemistry & Biochemistry Ohio State University Emel Adaligil Principal Scientific Manager, Macrocycle Discovery Group Genentech James Bowman Director of Protein Engineering AI Proteins Jeffrey Schubert Principal Scientist Merck John Tan Director, Informatics Nimble Therapeutics Joshua Schwochert Co-founder & Chief Scientific Officer Unnatural Products Laura Nevola Co-Founder, Chief Scientific Officer & Chief Operating Officer IDP Pharma Lauren Goodrich-Berto Vice President - Therapeutic Discovery Nimble Therapeutics Mah Kheirabadi Director, Discovery Chemistry Entrada Therapeutics Inc. Manuel Sanchez-Felix Vice President, Drug Delivery Halozyme Therapeutics Markus Haeberlein Executive Vice President - Discovery Science Parabilis Medicines Meritxell Teixido CEO and Co-founder Gate2Brain S.L. Miriam Kidron Chief Scientific Officer Oramed Pharmaceuticals Patrick Salveson Co-Founder & Chief Technology Officer Vilya Pete Gough Chief Scientific Officer Nimble Therapeutics Ranganath Gopalakrishnan Director, New Modalities Medicinal Chemistry, Early CVRM AstraZeneca Rick Ewing Vice President & Head of Chemistry Rapafusyn Pharmaceuticals Robert Maguire Director of Chemistry Cybrexa Therapeutics Sevan Habeshian Co-founder & Chief Technology Officer Orbis Medicines Thomas Von Erlach Co-Founder & Chief Scientific Officer Vivtex Toby Passioura Co-Founder & Chief Scientific Officer Insamo Tomi Sawyer Chief Drug Hunter & President Maestro Therapeutics Xavier Michelet Director of Biology AI Proteins Yoshihisa Murata Head of Advanced Computational Chemistry Group Chugai Pharmaceutical Co Yu-Shan Lin Professor and Department Chair of Chemistry Tufts University